Investment Newsletters
Home
Top Nasdaq Stocks
Cannabis-Stock Buzz
Analyst Insights
All Sectors
Biotech Stocks
Technology Stocks
Consumer Stocks
Industrial Stocks
Financial Stocks
Stock News
All Sectors
Biotech Stocks
Technology stocks
Consumer Stocks
Industrial Stocks
Financial Stocks
Bloggers Corner
Investment newsletters
The Daily Insider
Bio Portfolio
The Big Short
Small-Cap Rockets
Go Sector
Investment newsletters
The Daily Insider
Bio Portfolio
The Big Short
Small-Cap Rockets
Go Sector
Guru Portfolio
J.P. Morgan
J.P. Morgan Reiterates Neutral Rating On MannKind Corporation; Remains Skeptical
J.P.
Ben Mahaney, Editor
—
February 26, 2015, 9:28 AM EDT
J.P. Morgan Reiterates Neutral Rating On Ariad Pharmaceuticals; Here‘s Why
J.P.
Ben Mahaney, Editor
—
February 19, 2015, 3:25 PM EDT
J.P. Morgan Raises Incyte Price Target Following 4Q Update
In a research report sent to investors today, J.P.
Jason Cohen
—
February 12, 2015, 4:12 PM EDT
J.P. Morgan Maintains Overweight On Gilead Sciences Following Earnings; Sees 17% Upside
J.P.
Jason Cohen
—
February 4, 2015, 4:46 PM EDT
J.P. Morgan Comments On Gilead Sciences Following HCV Weekly Rx Update
J.P.
Ben Mahaney, Editor
—
January 20, 2015, 12:14 PM EDT
Novavax: Analyst Cory Kasimov Provides Update From The J.P. Morgan Healthcare Conference
J.P.
Jason Cohen
—
January 15, 2015, 11:50 AM EDT
MannKind: Analyst Cory Kasimov Provides Update From The J.P. Morgan Healthcare Conference
J.P.
Ben Mahaney, Editor
—
January 15, 2015, 10:15 AM EDT
Ziopharm: Analyst Cory Kasimov Provides Update From The J.P. Morgan Healthcare Conference
J.P.
Ben Mahaney, Editor
—
January 15, 2015, 9:49 AM EDT
J.P. Morgan Comments On Ziopharm Oncology Following Licensing Agreement With The University Of Texas
J.P.
Ben Mahaney, Editor
—
January 14, 2015, 5:58 PM EDT
Keryx: Analyst Cory Kasimov Provides Update From The J.P. Morgan Healthcare Conference
J.P.
Corey Williams
—
January 14, 2015, 12:38 PM EDT
«
1
…
10
11
12
13
»
x
Stay Ahead of Everyone Else
Get The Latest
Stock News Alerts